.
BioEnterprise

Myomo Launches Initial Public Offering Via Jobs Act Regulation A+

Myomo, makers of the MyoPro, announces a Regulation A+ initial public offering, allowing any investor the opportunity to invest in the company’s vision for expanded mobility for those suffering from neurological disorders and upper limb paralysis.

Read More  >